Global and China Personalized Medicines In Oncology Market Size, Status and Forecast 2024-2031

Report ID: 1025137 | Published Date: Sep 2024 | No. of Page: 107 | Base Year: 2023 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%)

Global Personalized Medicines In Oncology Scope and Market Size
Personalized Medicines In Oncology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Personalized Medicines In Oncology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Molecular Oncopathology
Genome Diagnostics
Radiation Therapy
Oncology Testing
Chemotherapy
Others

Segment by Application
Research Centers
Governmental Institutions
Hospitals
Clinical Centers
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Biotheranostics
Illumina
DNA Link
Genomic Health, Inc.(Exact Sciences)
Cypher Genomics(Human Longevity, Inc.)
Life Technologies Corporation(Thermo Fisher Scientific)
Fulgent Genetics
Caris Life Sciences
Ariana Pharma
Abbott Laboratories
deCODE genetics
Exagen Inc

Frequently Asked Questions
Personalized Medicines In Oncology report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Personalized Medicines In Oncology report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Personalized Medicines In Oncology report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports